American Association for Cancer Research

Skip to Main Content

Table 5

Patient response

		Drug response^a									Survival (mo)
Response	n	T sens P resist	T sens P sens	T resist P resist	T resist P sens	%	95% confidence interval	Median	Range
CR	1		1			7%	0.2% –32%
PR	4		2	2		26%	8%–55%	9.8	5.9–22.9
CR + PR	5		3	2		33%	12% –62%
Stb. D	0					0 %
PD	10	1	3	5	1	67%

		Drug response^a									Survival (mo)
Response	n	T sens P resist	T sens P sens	T resist P resist	T resist P sens	%	95% confidence interval	Median	Range
CR	1		1			7%	0.2% –32%
PR	4		2	2		26%	8%–55%	9.8	5.9–22.9
CR + PR	5		3	2		33%	12% –62%
Stb. D	0					0 %
PD	10	1	3	5	1	67%

^a

T, paclitaxel; sens, sensitive; resist, resistant; P, platinum; Stb. D, stable disease; PD, progressive disease. Two patients were not evaluable.